Ignite Creation Date:
2025-12-24 @ 10:49 PM
Ignite Modification Date:
2026-03-01 @ 8:59 PM
Study NCT ID:
NCT02891369
Status:
COMPLETED
Last Update Posted:
2018-08-14
First Post:
2016-09-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Analysis of Patients Treated With Bevacizumab Intraperitoneal for the Treatment of Refractory Malignant Ascites
Sponsor:
Fondation Hôpital Saint-Joseph
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02
Start Date Type:
None
Primary Completion Date:
2015-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-05
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-01
First Submit QC Date:
None
Study First Post Date:
2016-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-10
Last Update Post Date:
2018-08-14
Last Update Post Date Type:
ACTUAL